The Advancing Role of Nanocomposites in Cancer Diagnosis and Treatment
Vivian Andoh,Dickson Ocansey,Hassan Naveed,Naijian Wang,Liang Chen,Keping Chen,Fei Mao
DOI: https://doi.org/10.2147/ijn.s471360
IF: 7.033
2024-06-20
International Journal of Nanomedicine
Abstract:Vivian Andoh, 1, &ast Dickson Kofi Wiredu Ocansey, 2, 3, &ast Hassan Naveed, 1 Naijian Wang, 4 Liang Chen, 1 Keping Chen, 1 Fei Mao 2 1 School of Life Sciences, Jiangsu University, Zhenjiang, People's Republic of China; 2 Department of Laboratory Medicine, Lianyungang Clinical College, Jiangsu University, Lianyungang, Jiangsu, People's Republic of China; 3 Directorate of University Health Services, University of Cape Coast, Cape Coast, Central Region, CC0959347, Ghana; 4 Key Laboratory of Medical Science and Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China &astThe first two authors contributed equally to this work Correspondence: Fei Mao, Department of Laboratory Medicine, Lianyungang Clinical College, Jiangsu University, Lianyungang, Jiangsu, 222006, People's Republic of China, Tel/Fax +86 511 8503 8215, Email The relentless pursuit of effective cancer diagnosis and treatment strategies has led to the rapidly expanding field of nanotechnology, with a specific focus on nanocomposites. Nanocomposites, a combination of nanomaterials with diverse properties, have emerged as versatile tools in oncology, offering multifunctional platforms for targeted delivery, imaging, and therapeutic interventions. Nanocomposites exhibit great potential for early detection and accurate imaging in cancer diagnosis. Integrating various imaging modalities, such as magnetic resonance imaging (MRI), computed tomography (CT), and fluorescence imaging, into nanocomposites enables the development of contrast agents with enhanced sensitivity and specificity. Moreover, functionalizing nanocomposites with targeting ligands ensures selective accumulation in tumor tissues, facilitating precise imaging and diagnostic accuracy. On the therapeutic front, nanocomposites have revolutionized cancer treatment by overcoming traditional challenges associated with drug delivery. The controlled release of therapeutic agents from nanocomposite carriers enhances drug bioavailability, reduces systemic toxicity, and improves overall treatment efficacy. Additionally, the integration of stimuli-responsive components within nanocomposites enables site-specific drug release triggered by the unique microenvironment of the tumor. Despite the remarkable progress in the field, challenges such as biocompatibility, scalability, and long-term safety profiles remain. This article provides a comprehensive overview of recent developments, challenges, and prospects, emphasizing the transformative potential of nanocomposites in revolutionizing the landscape of cancer diagnostics and therapeutics. In Conclusion, integrating nanocomposites in cancer diagnosis and treatment heralds a new era for precision medicine. Keywords: nanocomposites, cancer, diagnosis, therapy, nanoparticles, theranostic Graphical Nanocomposites belong to a broader class of intentionally produced materials called nanomaterials, which incorporate nanosized particles into a matrix of standard materials. These nanosized particles can have one, two, or three dimensions of less than 100 nanometers. 1 Integrating nanoscale components imparts unique characteristics to the composite material, making nanocomposites valuable in various applications, including healthcare. 2 The tunable properties of nanocomposites, such as biocompatibility, stimuli responsiveness, and functionality, have deemed them ideal platforms for diagnosing and treating chronic diseases, including cancer, diabetes, and cardiovascular disease. 2,3 In the phase of increasing cancer cases and deaths, there is a growing global cancer burden and a need for effective theranostic strategies. Researchers aim to speed up cancer diagnosis with efforts to reduce waiting times and enhance the efficiency of the diagnostic process for patients. 4 Nanocomposites have emerged as unique particles, promising to revolutionize cancer diagnosis and treatment. In their specific application in cancer, nanocomposites play a crucial role in advancing cancer diagnosis and treatment as they are employed in various applications for precise and effective strategies in the fight against cancer. 5 While nanomaterials contribute to precise applications for cancer detection and diagnosis, aiming to synthesize nanomaterials for improved efficacy, 6 nanotechnology, which encompasses applications like drug delivery, has yielded promising results in cancer diagnosis and treatment and continues to contribute to advancements in the field. 7 For instance, the application of molybdenum disulfide (MoS 2 )-based nanocomposites, including i -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology